<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.xmethod.app/index.php?action=history&amp;feed=atom&amp;title=Hyperkalemia_Treatment_%28E.A.T._D.I.C.K.%29</id>
	<title>Hyperkalemia Treatment (E.A.T. D.I.C.K.) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.xmethod.app/index.php?action=history&amp;feed=atom&amp;title=Hyperkalemia_Treatment_%28E.A.T._D.I.C.K.%29"/>
	<link rel="alternate" type="text/html" href="https://wiki.xmethod.app/index.php?title=Hyperkalemia_Treatment_(E.A.T._D.I.C.K.)&amp;action=history"/>
	<updated>2026-11-08T12:39:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>https://wiki.xmethod.app/index.php?title=Hyperkalemia_Treatment_(E.A.T._D.I.C.K.)&amp;diff=139&amp;oldid=prev</id>
		<title>Docmoates: Add Nursing Mnemonics category and pages</title>
		<link rel="alternate" type="text/html" href="https://wiki.xmethod.app/index.php?title=Hyperkalemia_Treatment_(E.A.T._D.I.C.K.)&amp;diff=139&amp;oldid=prev"/>
		<updated>2026-09-09T11:22:56Z</updated>

		<summary type="html">&lt;p&gt;Add Nursing Mnemonics category and pages&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== The mnemonic ==&lt;br /&gt;
For severe &amp;#039;&amp;#039;&amp;#039;hyperkalemia&amp;#039;&amp;#039;&amp;#039; (elevated serum potassium), a nursing student asked what to do for a potassium of 7.1 mEq/L. The answer, as a memory aid: &amp;#039;&amp;#039;&amp;#039;E.A.T. D.I.C.K.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
;E&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;EKG&amp;#039;&amp;#039;&amp;#039; — get a 12-lead / continuous cardiac monitoring immediately. Hyperkalemia is a cardiac emergency; ECG changes (peaked T waves, widened QRS, flattened P waves, eventual sine wave pattern) drive urgency and treatment sequencing.&lt;br /&gt;
;A&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Albuterol&amp;#039;&amp;#039;&amp;#039; — nebulized beta-2 agonist. Shifts potassium intracellularly (temporary, does not remove potassium from the body).&lt;br /&gt;
;T&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Telemetry&amp;#039;&amp;#039;&amp;#039; — continuous cardiac monitoring throughout treatment; hyperkalemia can cause fatal dysrhythmias with little warning.&lt;br /&gt;
;D&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Dextrose&amp;#039;&amp;#039;&amp;#039; — given with insulin (see next letter) to prevent hypoglycemia while insulin drives potassium into cells.&lt;br /&gt;
;I&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Insulin&amp;#039;&amp;#039;&amp;#039; — IV regular insulin is one of the fastest ways to shift potassium intracellularly; always given with dextrose unless the patient is already hyperglycemic.&lt;br /&gt;
;C&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Calcium&amp;#039;&amp;#039;&amp;#039; (gluconate or chloride) — does &amp;#039;&amp;#039;&amp;#039;not&amp;#039;&amp;#039;&amp;#039; lower serum potassium. It stabilizes the cardiac cell membrane and is given first, before the potassium-lowering measures, when ECG changes are present, to protect the heart while the other interventions take effect.&lt;br /&gt;
;K&lt;br /&gt;
:&amp;#039;&amp;#039;&amp;#039;Kayexelate&amp;#039;&amp;#039;&amp;#039; (sodium polystyrene sulfonate) or &amp;#039;&amp;#039;&amp;#039;Lokelma&amp;#039;&amp;#039;&amp;#039; (patiromer/sodium zirconium cyclosilicate) — these are the interventions that actually &amp;#039;&amp;#039;&amp;#039;remove&amp;#039;&amp;#039;&amp;#039; potassium from the body (via the GI tract), rather than just shifting it intracellularly. Slower onset than the measures above. Dialysis is the definitive treatment for severe or refractory cases.&lt;br /&gt;
&lt;br /&gt;
== Why the sequence matters ==&lt;br /&gt;
Notice the mnemonic is not strictly in clinical priority order — in practice, if ECG changes are present, IV calcium is given first to stabilize the myocardium, then the potassium-shifting measures (insulin/dextrose, albuterol) are given rapidly, and finally the potassium-removing measures (Kayexelate/Lokelma, dialysis) address the underlying total-body potassium load. The letters spell something memorable; the actual bedside order is calcium → shift → remove, all while on continuous cardiac monitoring.&lt;br /&gt;
&lt;br /&gt;
== Practice question ==&lt;br /&gt;
==Question==&lt;br /&gt;
A client&amp;#039;s potassium level returns at 7.1 mEq/L and the ECG shows peaked T waves and a widening QRS. Which intervention should the nurse anticipate &amp;#039;&amp;#039;&amp;#039;first&amp;#039;&amp;#039;&amp;#039;?&lt;br /&gt;
# Sodium polystyrene sulfonate (Kayexelate) orally&lt;br /&gt;
# IV calcium gluconate&lt;br /&gt;
# Nebulized albuterol&lt;br /&gt;
# Hemodialysis&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Answer:&amp;#039;&amp;#039;&amp;#039; 2 (IV calcium gluconate)&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;Rationale:&amp;#039;&amp;#039; With ECG changes present, cardiac membrane stabilization is the immediate priority — calcium does not lower the potassium level but protects the heart from lethal dysrhythmias while potassium-shifting and potassium-removing therapies are initiated. Kayexelate and dialysis remove potassium but act too slowly to be first-line in an unstable rhythm; albuterol shifts potassium but does not protect the myocardium the way calcium does.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
Kraft, M. D., Btaiche, I. F., Sacks, G. S., &amp;amp;amp; Kudsk, K. A. (2005). Treatment of electrolyte disorders in adult patients in the intensive care unit. &amp;#039;&amp;#039;American Journal of Health-System Pharmacy, 62&amp;#039;&amp;#039;(16), 1663-1682.&lt;br /&gt;
&lt;br /&gt;
Rossignol, P., Legrand, M., Kosiborod, M., Hollenberg, S. M., Peacock, W. F., Emmett, M., Epstein, M., Kovesdy, C. P., Yilmaz, M. B., Stough, W. G., Gayat, E., Pitt, B., Zannad, F., &amp;amp;amp; Mebazaa, A. (2016). Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. &amp;#039;&amp;#039;Pharmacological Research, 113&amp;#039;&amp;#039;, 585-591.&lt;br /&gt;
&lt;br /&gt;
[[Category:Nursing Mnemonics]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Reduction of Risk Potential]]&lt;br /&gt;
{{Disclaimer}}&lt;/div&gt;</summary>
		<author><name>Docmoates</name></author>
	</entry>
</feed>